Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, County Mayo, Ireland
Tear substitute. Treatment of the symptoms of dry eye.
Instil 1-2 drops in the affected eye/s 4 times a day or as needed.
Ensure that the single-dose container is intact before use. The eye drop solution should be used immediately after opening.
To avoid contamination or possible eye injury, do not touch tip of the bottle or vial to any surface and avoid contact with the eye.
If Celluvisc is concomitantly used with other ocular eye medications there must be an interval of at least 15 minutes between the two medications (as displacement of a medication may occur).
The eye drops may be used with contact lenses.
The safety and efficacy of Celluvisc in children and adolescents have been established by clinical experience, but no clinical trial data are available. The posology recommended in adults is recommended in the paediatric population.
Accidental overdose will present no hazard.
Shelf life: 18 months.
After first opening: Use immediately.
Do not store above 25ºC.
0.4 ml in LDPE single-dose container.
Pack sizes: 5, 30 or 90 single-dose containers.
Not all pack sizes may be marketed.
Discard any unused solution in opened container i.e. do not re-use container for subsequent doses.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
